SCHEMBL9656175

SCHEMBL9656175

CCOC(=O)Oc1c(C)c(OCC)c(OC(=O)OCC)c2ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.40
TYMS P04818 1/20 0.39
CYP4F2 P78329 2/20 0.39
CYP4A11 Q02928 2/20 0.39
PTGER4 P35408 3/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2D6 P10635 1/20 0.39
MAOB P27338 1/20 0.38
ALDH1A1 P00352 3/20 0.37
GABRP O00591 1/20 0.37
GABRD O14764 1/20 0.37
GABRA1 P14867 1/20 0.37
GABRB1 P18505 1/20 0.37
GABRG2 P18507 1/20 0.37
GABRB3 P28472 1/20 0.37
GABRA5 P31644 1/20 0.37
GABRA3 P34903 1/20 0.37
GABRA2 P47869 1/20 0.37
GABRB2 P47870 1/20 0.37
GABRA4 P48169 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9657790 0.91 ALDH1A1 (0.41) TSHRCYP4F2CYP4A11PTGER4CYP1A2
SCHEMBL9656393 0.88 KDM4E (0.46) TSHRTYMSCYP4F2CYP4A11CYP1A2
SCHEMBL12315084 0.87 TSHR (0.47) TSHRTYMSCYP4F2CYP4A11CYP1A2
SCHEMBL9628321 0.86 KDM4E (0.50) TSHRPTGER4CYP1A2CYP2D6ALDH1A1
SCHEMBL9657819 0.85 ALDH1A1 (0.40) TSHRTYMSCYP4F2CYP4A11PTGER4
SCHEMBL10709274 0.85 PIN1 (0.38) TSHRCYP4F2CYP4A11PTGER4CYP1A2
SCHEMBL19583350 0.85 TSHR (0.48) TSHRTYMSCYP4F2CYP4A11MAOB
SCHEMBL30004235 0.85 TSHR (0.48) TSHRTYMSCYP4F2CYP4A11MAOB
SCHEMBL9627063 0.84 ELANE (0.40) TSHRCYP4F2CYP4A11PTGER4CYP1A2
SCHEMBL11008110 0.83 CYP4F2 (0.38) TSHRCYP4F2CYP4A11PTGER4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5134161-A Enzyme inhibitors for skin disorders, antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1992-07-28 US disclosed
US-4786652-A TOPICAL ADMINISTRATION SYNTEX (U.S.A.) INC. (US) 1988-11-22 US disclosed
EP-0282006-A1 Naphtalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-09-14 EP disclosed